Pre-loaded with the Tirzepatide defaults from the literature. Adjust vial size, diluent, target dose, and syringe to fit your protocol. Supports mg, mcg, and IU.
Educational use only. This calculator performs unit math on the values you provide and is not a substitute for medical advice. Verify every calculation independently.
Numbers are computed from your inputs. Verify all calculations independently. Educational use only.
A dual GIP/GLP-1 receptor agonist showing greater weight and HbA1c reductions than single-incretin therapies in head-to-head trials.
Clinical escalation: 2.5 mg weekly for 4 weeks, then 5, 7.5, 10, 12.5, 15 mg at 4-week intervals as tolerated.
Lyophilized stable at 2–8°C. Refrigerate after reconstitution.
Confirm your vial size in mg (default 10), set the diluent volume in mL (default 2), enter your target dose, and the calculator returns the concentration, the exact insulin-syringe units to draw, and how many doses your vial yields.
Most Tirzepatide research protocols reconstitute a 10 mg vial with 2 mL of bacteriostatic water, yielding 5000 mcg/mL.
U-100 insulin syringes are standard for Tirzepatide subcutaneous administration. 0.5 mL barrels have clearer unit markings for typical research doses.
Yes. Enter your dose in mcg, mg, or IU. For IU, set the mcg-per-IU ratio (333 for HGH is a common default).